Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DEN52G
|
|||
| Drug Name |
OTB-658
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Tuberculosis [ICD-11: 1B10-1B14] | Preclinical | [1] | |
| Company |
TB
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Ribosome (Bact RIBS) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In Vitro and In Vivo Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421. | |||
| REF 2 | Clinical pipeline report, company report or official report of TB | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.